Related Experiment Videos
Using triazolam to reduce dental anxiety
C W Berthold1, A Schneider, R A Dionne
1Clinical Pharmacology Unit, National Institutes of Health, Bethesda, Md.
Journal of the American Dental Association (1939)
|November 1, 1993
Summary
Triazolam, a medication for insomnia, can safely reduce dental anxiety when used short-term at low doses. Research supports its safe application in dental procedures, despite public concerns.
Area of Science:
- Pharmacology
- Dental Anxiolytics
- Sleep Medicine
Background:
- Triazolam is a benzodiazepine primarily prescribed for insomnia.
- Public perception of triazolam's safety is influenced by controversial media reports.
- Dental anxiety is a significant barrier to oral healthcare access.
Purpose of the Study:
- To review the existing research on the safety of triazolam.
- To evaluate the efficacy of triazolam in reducing dental anxiety.
- To provide evidence-based guidance on the appropriate use of triazolam in dentistry.
Main Methods:
- Systematic review of preclinical and clinical studies on triazolam.
- Analysis of pharmacokinetic and pharmacodynamic data.
- Evaluation of adverse event profiles in relevant patient populations.
Main Results:
- Low-dose, short-term administration of triazolam is associated with a favorable safety profile.
- Studies indicate significant anxiolytic effects of triazolam in dental settings.
- Risk-benefit analysis supports its judicious use for managing dental anxiety.
Conclusions:
- Triazolam can be a safe and effective option for managing dental anxiety.
- Clinicians should consider low-dose, short-term triazolam regimens.
- Further research may clarify optimal dosing and patient selection criteria for dental use.